{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:55:52Z","timestamp":1787313352903,"version":"build-2736575974"},"reference-count":96,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pulmocide Ltd.","award":["Publication fee"],"award-info":[{"award-number":["Publication fee"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Allergy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In patients with asthma, the inhalation of elevated amounts of fungal spores and hyphae may precipitate the onset of asthma or worsen control to the extent of being life-threatening. Sensitisation to fungi, especially\n                    <jats:italic>Aspergillus fumigatus<\/jats:italic>\n                    , is found in 15% to 48% of asthmatics in secondary care and is linked to worse asthma control, hospitalisation, bronchiectasis and fixed airflow obstruction, irrespective of whether allergic bronchopulmonary aspergillosis (ABPA) is diagnosed. ABPA represents a florid response to the presence of\n                    <jats:italic>Aspergillus<\/jats:italic>\n                    spp. but up to 70% of patients with severe asthma exhibit sensitisation to different fungi without meeting the diagnostic criteria for ABPA. The presence of persistent endobronchial colonisation with fungi, especially\n                    <jats:italic>A. fumigatus<\/jats:italic>\n                    , is linked to significantly higher rates of radiological abnormalities, lower post-bronchodilator FEV1 and significantly less reversibility to short acting bronchodilators. The therapeutic benefit for antifungal intervention in severe asthma is based on the assumption that reductions in airway fungal burden may result in improvements in asthma control, lung function and symptoms (especially cough). This contention is supported by several prospective studies which demonstrate the effectiveness of antifungals for the treatment of ABPA. Significantly, these studies confirm lower toxicity of treatment with azoles versus high dose oral corticosteroid dosing regimens for ABPA. Here we review recent evidence for the role of fungi in the progression of severe asthma and provide recommendations for the use of antifungal agents in patients with severe asthma, airways fungal infection (mycosis) and fungal colonisation. Documenting fungal airways colonisation and sensitisation in those with severe asthma opens up alternative therapy options of antifungal therapy, which may be particularly valuable in low resource settings.\n                  <\/jats:p>","DOI":"10.1186\/s13601-020-00353-8","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T19:05:36Z","timestamp":1604603136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The role of antifungals in the management of patients with severe asthma"],"prefix":"10.1002","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5795-6500","authenticated-orcid":false,"given":"W. Garth","family":"Rapeport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"issue":"2","key":"353_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343\u201373.","journal-title":"Eur Respir J"},{"issue":"2","key":"353_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","volume":"127","author":"J Lotvall","year":"2011","unstructured":"Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355\u201360.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"353_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1183\/09031936.06.00074705","volume":"27","author":"DW Denning","year":"2006","unstructured":"Denning DW, O\u2019Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J. 2006;27(3):615\u201326.","journal-title":"Eur Respir J"},{"issue":"3","key":"353_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jaci.2013.04.007","volume":"132","author":"CG Baxter","year":"2013","unstructured":"Baxter CG, Dunn G, Jones AM, Webb K, Gore R, Richardson MD, et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. 2013;132(3):560\u20136.","journal-title":"J Allergy Clin Immunol."},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2045-7022-4-14","volume":"4","author":"DW Denning","year":"2014","unstructured":"Denning DW, Pashley C, Hartl D, Wardlaw A, Godet C, Del Giacco S, et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy. 2014;4:14.","journal-title":"Clin Transl Allergy"},{"issue":"8","key":"353_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/cea.12141","volume":"43","author":"R Agarwal","year":"2013","unstructured":"Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43(8):850\u201373.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"353_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/cea.12848","volume":"47","author":"KF Woolnough","year":"2017","unstructured":"Woolnough KF, Richardson M, Newby C, Craner M, Bourne M, Monteiro W, et al. The relationship between biomarkers of fungal allergy and lung damage in asthma. Clin Exp Allergy. 2017;47(1):48\u201356.","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"353_CR8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3109\/02770903.2016.1154073","volume":"53","author":"J Farrant","year":"2016","unstructured":"Farrant J, Brice H, Fowler S, Niven R. Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum. J Asthma. 2016;53(7):732\u20135.","journal-title":"J Asthma"},{"issue":"5","key":"353_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1398-9995.2010.02542.x","volume":"66","author":"D Menzies","year":"2011","unstructured":"Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66(5):679\u201385.","journal-title":"Allergy"},{"issue":"3","key":"353_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.chest.2018.01.005","volume":"153","author":"R Agarwal","year":"2018","unstructured":"Agarwal R, Dhooria S, Singh Sehgal I, Aggarwal AN, Garg M, Saikia B, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153(3):656\u201364.","journal-title":"Chest"},{"issue":"3","key":"353_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/02770903.2014.958853","volume":"52","author":"L Chishimba","year":"2015","unstructured":"Chishimba L, Langridge P, Powell G, Niven RM, Denning DW. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). J Asthma. 2015;52(3):289\u201395.","journal-title":"J Asthma"},{"issue":"5","key":"353_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/02770903.2015.1127935","volume":"53","author":"B Ram","year":"2016","unstructured":"Ram B, Aggarwal AN, Dhooria S, Sehgal IS, Garg M, Behera D, et al. A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis. J Asthma. 2016;53(5):517\u201324.","journal-title":"J Asthma"},{"issue":"4","key":"353_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/02770903.2012.662568","volume":"49","author":"L Chishimba","year":"2012","unstructured":"Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012;49(4):423\u201333.","journal-title":"J Asthma"},{"issue":"11","key":"353_CR14","doi-asserted-by":"publisher","first-page":"e47526","DOI":"10.1371\/journal.pone.0047526","volume":"7","author":"R Quansah","year":"2012","unstructured":"Quansah R, Jaakkola MS, Hugg TT, Heikkinen SA, Jaakkola JJ. Residential dampness and molds and the risk of developing asthma: a systematic review and meta-analysis. PLoS ONE. 2012;7(11):e47526.","journal-title":"PLoS ONE"},{"issue":"3","key":"353_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jaci.2012.05.030","volume":"130","author":"T Reponen","year":"2012","unstructured":"Reponen T, Lockey J, Bernstein DI, Vesper SJ, Levin L, Khurana Hershey GK, et al. Infant origins of childhood asthma associated with specific molds. J Allergy Clin Immunol. 2012;130(3):639\u201344.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"353_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/oemed-2012-100963","volume":"70","author":"D Norback","year":"2013","unstructured":"Norback D, Zock JP, Plana E, Heinrich J, Svanes C, Sunyer J, et al. Mould and dampness in dwelling places, and onset of asthma: the population-based cohort ECRHS. Occup Environ Med. 2013;70(5):325\u201331.","journal-title":"Occup Environ Med"},{"issue":"11","key":"353_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1136\/oem.57.11.786","volume":"57","author":"R Newson","year":"2000","unstructured":"Newson R, Strachan D, Corden J, Millington W. Fungal and other spore counts as predictors of admissions for asthma in the Trent region. Occup Environ Med. 2000;57(11):786\u201392.","journal-title":"Occup Environ Med"},{"issue":"9","key":"353_CR18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/oem.2005.024448","volume":"63","author":"RW Atkinson","year":"2006","unstructured":"Atkinson RW, Strachan DP, Anderson HR, Hajat S, Emberlin J. Temporal associations between daily counts of fungal spores and asthma exacerbations. Occup Environ Med. 2006;63(9):580\u201390.","journal-title":"Occup Environ Med"},{"issue":"9643","key":"353_CR19","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0140-6736(08)61447-6","volume":"372","author":"DA Stern","year":"2008","unstructured":"Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet. 2008;372(9643):1058\u201364.","journal-title":"Lancet"},{"issue":"6","key":"353_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/cea.13378","volume":"49","author":"H Backman","year":"2019","unstructured":"Backman H, Jansson SA, Stridsman C, Eriksson B, Hedman L, Eklund BM, et al. Severe asthma\u2014a population study perspective. Clin Exp Allergy. 2019;49(6):819\u201328.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"353_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jaip.2014.05.005","volume":"2","author":"A von Bulow","year":"2014","unstructured":"von Bulow A, Kriegbaum M, Backer V, Porsbjerg C. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2(6):759\u201367.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"353_CR22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","volume":"135","author":"PP Hekking","year":"2015","unstructured":"Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896\u2013902.","journal-title":"J Allergy Clin Immunol"},{"key":"353_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.rmed.2016.12.017","volume":"123","author":"S Varsano","year":"2017","unstructured":"Varsano S, Segev D, Shitrit D. Severe and non-severe asthma in the community: A large electronic database analysis. Respir Med. 2017;123:131\u20139.","journal-title":"Respir Med"},{"issue":"3","key":"353_CR24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jaci.2005.11.003","volume":"117","author":"MS Jaakkola","year":"2006","unstructured":"Jaakkola MS, Ieromnimon A, Jaakkola JJ. Are atopy and specific IgE to mites and molds important for adult asthma? J Allergy Clin Immunol. 2006;117(3):642\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"353_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jaci.2009.06.010","volume":"124","author":"V Siroux","year":"2009","unstructured":"Siroux V, Boudier A, Bousquet J, Bresson JL, Cracowski JL, Ferran J, et al. Phenotypic determinants of uncontrolled asthma. J Allergy Clin Immunol. 2009;124(4):681\u20137.","journal-title":"J Allergy Clin Immunol."},{"issue":"11","key":"353_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1111\/j.1365-2222.2009.03339.x","volume":"39","author":"BR O'Driscoll","year":"2009","unstructured":"O\u2019Driscoll BR, Powell G, Chew F, Niven RM, Miles JF, Vyas A, et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy. 2009;39(11):1677\u201383.","journal-title":"Clin Exp Allergy"},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2466-5-4","volume":"5","author":"BR O'Driscoll","year":"2005","unstructured":"O\u2019Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med. 2005;5:4.","journal-title":"BMC Pulm Med"},{"key":"353_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/JAA.S130459","volume":"10","author":"KJ Goh","year":"2017","unstructured":"Goh KJ, Yii ACA, Lapperre TS, Chan AK, Chew FT, Chotirmall SH, et al. Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma. J Asthma Allergy. 2017;10:131\u201340.","journal-title":"J Asthma Allergy"},{"issue":"3","key":"353_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1183\/09031936.00226911","volume":"41","author":"DW Denning","year":"2013","unstructured":"Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J. 2013;41(3):621\u20136.","journal-title":"Eur Respir J"},{"issue":"5","key":"353_CR30","doi-asserted-by":"publisher","first-page":"e0216568","DOI":"10.1371\/journal.pone.0216568","volume":"14","author":"R Kwizera","year":"2019","unstructured":"Kwizera R, Musaazi J, Meya DB, Worodria W, Bwanga F, Kajumbula H, et al. Burden of fungal asthma in Africa: a systematic review and meta-analysis. PLoS ONE. 2019;14(5):e0216568.","journal-title":"PLoS ONE"},{"issue":"12","key":"353_CR31","doi-asserted-by":"publisher","first-page":"e114745","DOI":"10.1371\/journal.pone.0114745","volume":"9","author":"R Agarwal","year":"2014","unstructured":"Agarwal R, Denning DW, Chakrabarti A. Estimation of the burden of chronic and allergic pulmonary aspergillosis in India. PLoS ONE. 2014;9(12):e114745.","journal-title":"PLoS ONE"},{"issue":"3","key":"353_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/myc.12427","volume":"59","author":"J Giacomazzi","year":"2016","unstructured":"Giacomazzi J, Baethgen L, Carneiro LC, Millington MA, Denning DW, Colombo AL, et al. The burden of serious human fungal infections in Brazil. Mycoses. 2016;59(3):145\u201350.","journal-title":"Mycoses"},{"key":"353_CR33","unstructured":"GAFFI, editor Burden of serious fungal disease in Latin America, by country and disease. Global Fungal Infection Forum 4 in Lima; 2019."},{"issue":"11","key":"353_CR34","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1164\/rccm.201001-0087OC","volume":"182","author":"A Fairs","year":"2010","unstructured":"Fairs A, Agbetile J, Hargadon B, Bourne M, Monteiro WR, Brightling CE, et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med. 2010;182(11):1362\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"353_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3109\/13693786.2011.615762","volume":"50","author":"CH Pashley","year":"2012","unstructured":"Pashley CH, Fairs A, Morley JP, Tailor S, Agbetile J, Bafadhel M, et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol. 2012;50(4):433\u20138.","journal-title":"Med Mycol"},{"issue":"2","key":"353_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4168\/aair.2017.9.2.177","volume":"9","author":"MA Ghebre","year":"2017","unstructured":"Ghebre MA, Desai D, Singapuri A, Woods J, Rapley L, Cohen S, et al. Sputum inflammatory mediators are increased in Aspergillus fumigatus culture-positive asthmatics. Allergy Asthma Immunol Res. 2017;9(2):177\u201381.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"5","key":"353_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1365-2222.2012.03987.x","volume":"42","author":"J Agbetile","year":"2012","unstructured":"Agbetile J, Fairs A, Desai D, Hargadon B, Bourne M, Mutalithas K, et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy. 2012;42(5):782\u201391.","journal-title":"Clin Exp Allergy"},{"key":"353_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1749-6632.2012.06816.x","volume":"1272","author":"A Chrdle","year":"2012","unstructured":"Chrdle A, Mustakim S, Bright-Thomas RJ, Baxter CG, Felton T, Denning DW. Aspergillus bronchitis without significant immunocompromise. Ann N Y Acad Sci. 2012;1272:73\u201385.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"353_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MCP.0000000000000129","volume":"21","author":"K Woolnough","year":"2015","unstructured":"Woolnough K, Fairs A, Pashley CH, Wardlaw AJ. Allergic fungal airway disease: pathophysiologic and diagnostic considerations. Curr Opin Pulm Med. 2015;21(1):39\u201347.","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"353_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.18176\/jiaci.0122","volume":"26","author":"EM Rick","year":"2016","unstructured":"Rick EM, Woolnough K, Pashley CH, Wardlaw AJ. Allergic Fungal Airway Disease. J Investig Allergol Clin Immunol. 2016;26(6):344\u201354.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"353_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.ai.2019.05.002","volume":"142","author":"E Li","year":"2019","unstructured":"Li E, Knight JM, Wu Y, Luong A, Rodriguez A, Kheradmand F, et al. Airway mycosis in allergic airway disease. Adv Immunol. 2019;142:85\u2013140.","journal-title":"Adv Immunol"},{"issue":"4","key":"353_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.alit.2015.05.007","volume":"64","author":"Y Fukutomi","year":"2015","unstructured":"Fukutomi Y, Taniguchi M. Sensitization to fungal allergens: resolved and unresolved issues. Allergol Int. 2015;64(4):321\u201331.","journal-title":"Allergol Int"},{"key":"353_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1471-2164-7-251","volume":"7","author":"P Bowyer","year":"2006","unstructured":"Bowyer P, Fraczek M, Denning DW. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genomics. 2006;7:251.","journal-title":"BMC Genomics"},{"issue":"1","key":"353_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1939-4551-6-17","volume":"6","author":"GW Canonica","year":"2013","unstructured":"Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, et al. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17.","journal-title":"World Allergy Organ J"},{"issue":"9","key":"353_CR45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/cea.13216","volume":"48","author":"V Muthu","year":"2018","unstructured":"Muthu V, Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: a systematic review and diagnostic test accuracy meta-analysis. Clin Exp Allergy. 2018;48(9):1107\u201336.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"353_CR46","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/ACI.0b013e32835535b8","volume":"12","author":"G Melioli","year":"2012","unstructured":"Melioli G, Compalati E, Bonini S, Canonica GW. The added value of allergen microarray technique to the management of poly-sensitized allergic patients. Curr Opin Allergy Clin Immunol. 2012;12(4):434\u20139.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"353_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11882-011-0217-4","volume":"11","author":"R Agarwal","year":"2011","unstructured":"Agarwal R. Severe asthma with fungal sensitization. Curr Allergy Asthma Rep. 2011;11(5):403\u201313.","journal-title":"Curr Allergy Asthma Rep"},{"key":"353_CR48","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.alit.2018.04.009","volume":"67S","author":"K Harada","year":"2018","unstructured":"Harada K, Oguma T, Saito A, Fukutomi Y, Tanaka J, Tomomatsu K, et al. Concordance between Aspergillus-specific precipitating antibody and IgG in allergic bronchopulmonary aspergillosis. Allergol Int. 2018;67S:S12\u20137.","journal-title":"Allergol Int"},{"issue":"4","key":"353_CR49","doi-asserted-by":"publisher","first-page":"E197","DOI":"10.1111\/1469-0691.12133","volume":"19","author":"CG Baxter","year":"2013","unstructured":"Baxter CG, Denning DW, Jones AM, Todd A, Moore CB, Richardson MD. Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin Microbiol Infect. 2013;19(4):E197-204.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"353_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/myc.12541","volume":"60","author":"R Agarwal","year":"2017","unstructured":"Agarwal R, Dua D, Choudhary H, Aggarwal AN, Sehgal IS, Dhooria S, et al. Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis. Mycoses. 2017;60(1):33\u20139.","journal-title":"Mycoses"},{"key":"353_CR51","first-page":"36","volume":"12","author":"K Asano","year":"2020","unstructured":"Asano K, Hebisawa A, Ishiguro T, Takayanagi N, Nakamura Y, Suzuki J, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation. J Allergy Clin Immunol. 2020;12:36.","journal-title":"J Allergy Clin Immunol."},{"key":"353_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/JCM.00538-19","volume":"57","author":"E Stucky Hunter","year":"2019","unstructured":"Stucky Hunter E, Richardson MD, Denning DW. Evaluation of LDBio Aspergillus ICT lateral flow assay for IgG and IgM antibody detection in chronic pulmonary aspergillosis. J Clin Microbiol. 2019;57:9.","journal-title":"J Clin Microbiol."},{"key":"353_CR53","first-page":"223","volume":"39","author":"E Stucky Hunter","year":"2020","unstructured":"Stucky Hunter E, Richardson M, Denning DW. Evaluation of the LDBio Aspergillus ICT lateral flow assay for serodiagnosis of allergic bronchopulmonary aspergillosis. PloS one. 2020;39:223.","journal-title":"PloS one."},{"issue":"9","key":"353_CR54","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1373\/clinchem.2006.067546","volume":"52","author":"E Van Hoeyveld","year":"2006","unstructured":"Van Hoeyveld E, Dupont L, Bossuyt X. Quantification of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? Clin Chem. 2006;52(9):1785\u201393.","journal-title":"Clin Chem"},{"issue":"5","key":"353_CR55","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/all.14087","volume":"75","author":"A Sullivan","year":"2020","unstructured":"Sullivan A, Hunt EB, Ward C, Lapthorne S, Eustace JA, Fanning LJ, et al. The presence of Aspergillus fumigatus in asthmatic airways is not clearly related to clinical disease severity. Allergy. 2020;75(5):1146\u201354.","journal-title":"Allergy"},{"issue":"2","key":"353_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jaci.2017.09.039","volume":"142","author":"MG Fraczek","year":"2018","unstructured":"Fraczek MG, Chishimba L, Niven RM, Bromley M, Simpson A, Smyth L, et al. Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease. J Allergy Clin Immunol. 2018;142(2):407\u201314.","journal-title":"J Allergy Clin Immunol"},{"key":"353_CR57","first-page":"8","volume":"9","author":"EM Rick","year":"2020","unstructured":"Rick EM, Woolnough KF, Seear PJ, Fairs A, Satchwell J, Richardson M, et al. The airway fungal microbiome in asthma. Clin Exp Allergy. 2020;9:8\u201318.","journal-title":"Clin Exp Allergy."},{"issue":"11","key":"353_CR58","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJM200003163421102","volume":"342","author":"DA Stevens","year":"2000","unstructured":"Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342(11):756\u201362.","journal-title":"N Engl J Med"},{"issue":"5","key":"353_CR59","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1067\/mai.2003.1388","volume":"111","author":"PA Wark","year":"2003","unstructured":"Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003;111(5):952\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"353_CR60","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/myc.12996","volume":"62","author":"AA Otu","year":"2019","unstructured":"Otu AA, Langridge P, Denning DW. An evaluation of nebulised amphotericin B deoxycholate (Fungizone((R)) ) for treatment of pulmonary aspergillosis in the UK National Aspergillosis Centre. Mycoses. 2019;62(11):1049\u201355.","journal-title":"Mycoses"},{"issue":"1","key":"353_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1164\/rccm.200805-737OC","volume":"179","author":"DW Denning","year":"2009","unstructured":"Denning DW, O\u2019Driscoll BR, Powell G, Chew F, Atherton GT, Vyas A, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med. 2009;179(1):11\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"353_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaci.2013.09.050","volume":"134","author":"J Agbetile","year":"2014","unstructured":"Agbetile J, Bourne M, Fairs A, Hargadon B, Desai D, Broad C, et al. Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study). J Allergy Clin Immunol. 2014;134(1):33\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"353_CR63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/CMR.00046-13","volume":"27","author":"T Felton","year":"2014","unstructured":"Felton T, Troke PF, Hope WW. Tissue penetration of antifungal agents. Clin Microbiol Rev. 2014;27(1):68\u201388.","journal-title":"Clin Microbiol Rev"},{"issue":"3\u20134","key":"353_CR64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1439-0507.2000.00565.x","volume":"43","author":"B Coronel","year":"2000","unstructured":"Coronel B, Levron JC, Dorez D, Van Devenne A, Archimbaud E, Mercatello A. Itraconazole lung concentrations in haematological patients. Mycoses. 2000;43(3\u20134):125\u20137.","journal-title":"Mycoses"},{"key":"353_CR65","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2147\/IDR.S170706","volume":"11","author":"J Zhang","year":"2018","unstructured":"Zhang J, Liu Y, Nie X, Yu Y, Gu J, Zhao L. Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis. Infect Drug Resist. 2018;11:1283\u201397.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"353_CR66","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1067\/mcp.2002.127397","volume":"72","author":"K Raaska","year":"2002","unstructured":"Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivisto KT. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole. Clin Pharmacol Ther. 2002;72(4):362\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"353_CR67","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/thorax.57.8.749","volume":"57","author":"JS Parmar","year":"2002","unstructured":"Parmar JS, Howell T, Kelly J, Bilton D. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax. 2002;57(8):749\u201350.","journal-title":"Thorax"},{"issue":"3 Pt 1","key":"353_CR68","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0091-6749(99)70321-0","volume":"104","author":"GW Ward Jr","year":"1999","unstructured":"Ward GW Jr, Woodfolk JA, Hayden ML, Jackson S, Platts-Mills TA. Treatment of late-onset asthma with fluconazole. J Allergy Clin Immunol. 1999;104(3 Pt 1):541\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"8643","key":"353_CR69","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(89)92863-8","volume":"1","author":"GW Ward Jr","year":"1989","unstructured":"Ward GW Jr, Karlsson G, Rose G, Platts-Mills TA. Trichophyton asthma: sensitisation of bronchi and upper airways to dermatophyte antigen. Lancet. 1989;1(8643):859\u201362.","journal-title":"Lancet"},{"issue":"4","key":"353_CR70","first-page":"1","volume":"5","author":"M Mirsadraee","year":"2019","unstructured":"Mirsadraee M, Dehghan S, Ghaffari S, Mirsadraee N. Long-term effect of antifungal therapy for the treatment of severe resistant asthma: an active comparator clinical trial. Curr Med Mycol. 2019;5(4):1\u20137.","journal-title":"Curr Med Mycol"},{"issue":"2","key":"353_CR71","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1378\/chest.130.2.442","volume":"130","author":"R Agarwal","year":"2006","unstructured":"Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest. 2006;130(2):442\u20138.","journal-title":"Chest"},{"issue":"10","key":"353_CR72","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/cea.12333","volume":"44","author":"AS Moreira","year":"2014","unstructured":"Moreira AS, Silva D, Ferreira AR, Delgado L. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy. 2014;44(10):1210\u201327.","journal-title":"Clin Exp Allergy"},{"key":"353_CR73","first-page":"2204","volume":"11","author":"HE Elphick","year":"2016","unstructured":"Elphick HE, Southern KW. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2016;11:2204.","journal-title":"Cochrane Database Syst Rev."},{"key":"353_CR74","unstructured":"ClinicalTrialsgov. Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis, NCT03960606 \n                  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT039606062019\n                  \n                . \n                  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03960606\n                  \n                ."},{"issue":"4","key":"353_CR75","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/bcp.14166","volume":"86","author":"DL Hava","year":"2020","unstructured":"Hava DL, Tan L, Johnson P, Curran AK, Perry J, Kramer S, et al. A phase 1\/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics. Br J Clin Pharmacol. 2020;86(4):723\u201333.","journal-title":"Br J Clin Pharmacol"},{"key":"353_CR76","unstructured":"ClinicalTiralsgov. Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects, NCT04229303 2020. \n                  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04229303\n                  \n                ."},{"key":"353_CR77","unstructured":"TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial [press release]. \n                  https:\/\/ir.tffpharma.com\/news-releases\/news-release-details\/tff-pharmaceuticals-announces-topline-results-voriconazole2020\n                  \n                ."},{"key":"353_CR78","unstructured":"ClinicalTiralsgov. The Effect of PC945 on Aspergillus or candida lung infections in patients with asthma or chronic respiratory diseases, NCT03745196 \n                  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT037451962018\n                  \n                . \n                  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03745196\n                  \n                ."},{"issue":"5","key":"353_CR79","doi-asserted-by":"publisher","first-page":"e02280","DOI":"10.1128\/AAC.02280-16","volume":"61","author":"T Colley","year":"2017","unstructured":"Colley T, Alanio A, Kelly SL, Sehra G, Kizawa Y, Warrilow AGS, et al. In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection. Antimicrob Agents Chemother. 2017;61(5):e02280-e2316.","journal-title":"Antimicrob Agents Chemother"},{"key":"353_CR80","unstructured":"FDA. Workshop: Addressing Challenges in Inhaled Antifungal Drug Development 2020. \n                  https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/addressing-challenges-inhaled-antifungal-drug-development-09252020-09252020\n                  \n                ."},{"issue":"2","key":"353_CR81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000441687","volume":"168","author":"BP Kaur","year":"2015","unstructured":"Kaur BP, Lahewala S, Arora S, Agnihotri K, Panaich SS, Secord E, et al. Asthma: Hospitalization Trends and Predictors of In-Hospital Mortality and Hospitalization Costs in the USA (2001\u20132010). Int Arch Allergy Immunol. 2015;168(2):71\u20138.","journal-title":"Int Arch Allergy Immunol"},{"key":"353_CR82","unstructured":"WHO. the 21st WHO Essential Medicines List (EML) \n                  https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/2019\n                  \n                . \n                  https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/\n                  \n                ."},{"key":"353_CR83","unstructured":"GAFFI. Antifungal drug maps. 2020. \n                  https:\/\/www.gaffi.org\/antifungal-drug-maps\/"},{"key":"353_CR84","unstructured":"Prats JAGG, Denning DW. Aspergillus bronchitis \n                  https:\/\/www.aspergillus.org.uk\/content\/aspergillus-bronchitis\n                  \n                : Aspergillus & Aspergillosis Website; 2016. \n                  https:\/\/www.aspergillus.org.uk\/content\/aspergillus-bronchitis\n                  \n                ."},{"issue":"1","key":"353_CR85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/thx.42.1.26","volume":"42","author":"DJ Shale","year":"1987","unstructured":"Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax. 1987;42(1):26\u201331.","journal-title":"Thorax"},{"issue":"9","key":"353_CR86","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1439-0507.1988.tb03653.x","volume":"31","author":"K De Beule","year":"1988","unstructured":"De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N, et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982\u20131987). Mycoses. 1988;31(9):476\u201385.","journal-title":"Mycoses"},{"issue":"6","key":"353_CR87","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/thx.45.6.447","volume":"45","author":"DC Currie","year":"1990","unstructured":"Currie DC, Lueck C, Milburn HJ, Harvey C, Longbottom JL, Darbyshire JH, et al. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax. 1990;45(6):447\u201350.","journal-title":"Thorax"},{"issue":"3","key":"353_CR88","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1378\/chest.100.3.813","volume":"100","author":"DW Denning","year":"1991","unstructured":"Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest. 1991;100(3):813\u20139.","journal-title":"Chest"},{"issue":"3","key":"353_CR89","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1378\/chest.107.3.883","volume":"107","author":"P Germaud","year":"1995","unstructured":"Germaud P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest. 1995;107(3):883.","journal-title":"Chest"},{"issue":"6","key":"353_CR90","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1378\/chest.116.6.1665","volume":"116","author":"F Salez","year":"1999","unstructured":"Salez F, Brichet A, Desurmont S, Grosbois JM, Wallaert B, Tonnel AB. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest. 1999;116(6):1665\u20138.","journal-title":"Chest"},{"issue":"2","key":"353_CR91","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0377-1237(04)80101-1","volume":"60","author":"SP Rai","year":"2004","unstructured":"Rai SP, Panda BN, Bhargava S. Treatment of Allergic Bronchopulmonary Aspergillosis with Fluconazole and Itraconazole. Med J Armed Forces India. 2004;60(2):128\u201330.","journal-title":"Med J Armed Forces India"},{"issue":"8","key":"353_CR92","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1440-1843.2009.01640.x","volume":"14","author":"AC Pasqualotto","year":"2009","unstructured":"Pasqualotto AC, Powell G, Niven R, Denning DW. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis. Respirology. 2009;14(8):1121\u20137.","journal-title":"Respirology"},{"key":"353_CR93","first-page":"3","volume":"52","author":"R Agarwal","year":"2018","unstructured":"Agarwal R, Dhooria S, Sehgal IS, Aggarwal AN, Garg M, Saikia B, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2018;52:3.","journal-title":"Eur Respir J."},{"key":"353_CR94","unstructured":"Committee on Infectious Diseases AAoP, Kimberlin, D.W., Brady, M.T., Jackson, M.A., Long, S.S. Report of the Committee on Infectious Disease, Section 3: Summaries of Infectious Disease 2018."},{"key":"353_CR95","unstructured":"MIMS. Drugs \n                  https:\/\/www.mims.co.uk\/\n                  \n                : Haymarket Media Group Ltd. ; 2020."},{"key":"353_CR96","unstructured":"Akuthota P, Weller PF. Treatment of allergic bronchopulmonary aspergillosis \n                  https:\/\/www.uptodate.com\/contents\/treatment-of-allergic-bronchopulmonary-aspergillosis\n                  \n                . Wolters Kluwer; 2018."}],"container-title":["Clinical and Translational Allergy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13601-020-00353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13601-020-00353-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13601-020-00353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T17:44:07Z","timestamp":1609436647000},"score":1,"resource":{"primary":{"URL":"https:\/\/ctajournal.biomedcentral.com\/articles\/10.1186\/s13601-020-00353-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1186\/s13601-020-00353-8","relation":{},"ISSN":["2045-7022"],"issn-type":[{"value":"2045-7022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Rapeport is a co-founder, former employee and shareholder in Pulmocide Ltd. Dr. Ito is a current employee and holds share options in Pulmocide Ltd. Dr. Denning and family hold Founder shares in F2G Ltd, a University of Manchester spin-out antifungal discovery company. He acts or has recently acted as a consultant to Scynexis, Pulmatrix, Pulmocide, Zambon, iCo Therapeutics, Mayne Pharma, Roivant, Biosergen, Bright Angel Therapeutics and Fujifilm. In the last 3\u00a0years, he has been paid for talks on behalf of Dynamiker, Hikma, Gilead, Merck, Mylan and Pfizer. He is a longstanding member of the Infectious Disease Society of America Aspergillosis Guidelines group, the European Society for Clinical Microbiology and Infectious Diseases Aspergillosis Guidelines group.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}